[artículo] 
inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 68-70

Título :	The effect of orlistat on plasma levels of psychotropic drugs in patients with long-term psychopharmacotherapy
Tipo de documento:	texto impreso
Autores:	Eva Hilger, Autor ; Sylvia Quiner, Autor ; Isabell Ginzel, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 68-70
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Interacción medicamentosa, Farmacoterapia, Lactonas, Medicamentos Psicotrópicos.
Resumen:	Weight gain induced by long-term psychopharmacotherapy has emerged as a relevant clinical issue because it is a major problem affecting compliance and long-term outcome. The novel antiobesity drug orlistat inhibits gastrointestinal lipases, thus lowering the absorption of dietary fat and raising the possibility of decreased absorption of fat-soluble vitamins and certain concomitantly administered drugs in some individuals.
Link:	./index.php?lvl=notice_display&id=31096

[artículo] The effect of orlistat on plasma levels of psychotropic drugs in patients with long-term psychopharmacotherapy [texto impreso] / Eva Hilger, Autor ; Sylvia Quiner, Autor ; Isabell Ginzel, Autor . - 2023 . - pp. 68-70.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 68-70

Palabras clave:	Interacción medicamentosa, Farmacoterapia, Lactonas, Medicamentos Psicotrópicos.
Resumen:	Weight gain induced by long-term psychopharmacotherapy has emerged as a relevant clinical issue because it is a major problem affecting compliance and long-term outcome. The novel antiobesity drug orlistat inhibits gastrointestinal lipases, thus lowering the absorption of dietary fat and raising the possibility of decreased absorption of fat-soluble vitamins and certain concomitantly administered drugs in some individuals.
Link:	./index.php?lvl=notice_display&id=31096